Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Research Articles
Iron Chelators, Such as Deferasirox, When Combined With Hydroxyurea, Provide an Additional Benefit of Iron Chelation in Patients Receiving Chronic Transfusion Therapy
Konstantinos Manganasa Thalassaemia and Sickle Cell Department, Hippokration General Hospital, Athens, GreeceCorrespondence[email protected]
https://orcid.org/0000-0002-9844-2813
https://orcid.org/0000-0002-9844-2813, Sophia Delicoua Thalassaemia and Sickle Cell Department, Hippokration General Hospital, Athens, Greecehttps://orcid.org/0000-0002-7049-6131
https://orcid.org/0000-0002-7049-6131, Aikaterini Xydakia Thalassaemia and Sickle Cell Department, Hippokration General Hospital, Athens, Greecehttps://orcid.org/0000-0002-6559-7026
https://orcid.org/0000-0002-6559-7026 & John Koskinasb Department of Internal Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greecehttps://orcid.org/0000-0003-4375-4454
https://orcid.org/0000-0003-4375-4454